Dapure-SM Tablet ER
Marketer
Ampure Pharmaceutical LLP
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Dapure-SM Tablet ER
Extended-release Dapure-SM tablets are a dual-action medication formulated to manage blood glucose. This medication complements diet and exercise, enhancing glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin efficacy, consequently reducing blood sugar. Dapure-SM ER tablets may be administered with or without food, but consistent daily timing is recommended. Dosage should be determined and monitored by your physician; discontinuation without their guidance can lead to elevated blood glucose and increase the risk of severe complications such as nephropathy and vision impairment. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Commonly reported adverse effects include urinary infections, nasal stuffiness, pharyngitis, and upper respiratory infections. Adequate hydration is crucial to mitigate dehydration. Genital candidiasis may occur in some individuals; diligent hygiene practices can help minimize this risk. Prior to commencing Dapure-SM ER therapy, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical counsel before initiating this medication. Limit alcohol consumption during treatment, as it may potentiate certain side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Dapure-SM Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Dapure-SM Tablet ER
Managing type 2 diabetes
Major Benefits of Dapure-SM Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapure-SM Extended-Release tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapure-SM Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Cough
How to use Dapure-SM Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapure-SM Tablet ER whole; avoid chewing, crushing, or breaking it. This extended-release tablet can be administered with or without food, although consistent timing is recommended.
How Dapure-SM Tablet ER works:
Dapure-SM Extended-Release tablets contain a triple-action formulation to manage blood sugar. Dapagliflozin works by eliminating excess glucose through the urine, lowering blood glucose concentrations. Metformin reduces glucose absorption from ingested food and hepatic glucose production. Furthermore, metformin enhances insulin sensitivity, improving the body's natural blood sugar regulation. Sitagliptin boosts incretin levels, stimulating the pancreas to secrete more insulin and suppressing excessive liver glucose output.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dapure-SM Tablet ER is unstudied regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The safety of Dapure-SM Tablet ER during pregnancy is unknown. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Dapure-SM Extended-Release Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Dapure-SM tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Dapure-SM Extended-Release Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Dapure-SM Extended-Release Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Dapure-SM Tablet ER :
Should you forget a Dapure-SM Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapure-SM Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



